Brevan Howard Capital Management’s GoodRx Holdings GDRX Stock Holding History

Brevan Howard Capital Management’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-27,233	Closed	-$53.4K	–	2244
2026 Q1	$53.4K	Sell	27,233 -220,856	-89%	-$518K	﹤0.01%	2080
2025 Q4	$672K	Buy	248,089 +152,606	+160%	+$501K	0.01%	950
2025 Q3	$404K	Buy	95,483 +6,842	+8%	+$30.1K	﹤0.01%	1398
2025 Q2	$441K	Buy	+88,641	New	+$385K	﹤0.01%	1406
2025 Q1	–	Sell	-31,776	Closed	-$148K	–	1266
2024 Q4	$148K	Buy	+31,776	New	+$175K	﹤0.01%	941

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SLG

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PTC

Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Brevan Howard Capital Management's GDRX Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of GoodRx Holdings (GDRX) in Q2 2026, closing a stake of 27,233 shares — an estimated $53.4K sold.

Brevan Howard Capital Management first reported a position in GDRX in Q4 2024 and held it in 5 quarters. The position peaked at $672K in Q4 2025. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

Brevan Howard Capital Management reported no remaining GoodRx Holdings position as of Q2 2026 after selling out during the quarter.
Brevan Howard Capital Management sold 27,233 GoodRx Holdings shares in Q2 2026, an estimated $53.4K.
Brevan Howard Capital Management first reported a position in GoodRx Holdings in Q4 2024 and held it in 5 quarters.
Brevan Howard Capital Management's GoodRx Holdings position peaked at $672K in Q4 2025.
162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.